Caredx celebrates 1 million organ transplants and 100,000 patient milestone

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it has served its 100,000th transplant patient, representing one out of ten patients transplanted in the u.s. this milestone demonstrates strong clinical adoption of molecular surveillance for transplant patients and showcase
CDNA Ratings Summary
CDNA Quant Ranking